Authorized purpose: Cardiac MRI ventricular function and 2D phase-contrast flow quantification
Clinical role
Segmentation and measurement support
Images and patients
MRI · Heart/Cardiovascular
Key limitation
Keep in mind: 2D flow model is not for patients under 18, 4D flow, extreme congenital distortion or low-SNR data; clinician review/editing is required.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Cardiac MRI ventricular function and 2D phase-contrast flow quantification
Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Heart/Cardiovascular Input: DICOM 1.5T or 3T cardiac MR cine and two-dimensional phase-contrast flow acquisitions
Who uses it?Intended users: Trained medical professionals interpreting cardiac MR
What does the software produce?Output: LV/RV volumes, ejection fraction, mass and indexed measurements; aortic/pulmonary vessel masks and forward/backward/net flow, regurgitant fraction, maximum velocity and pressure gradient.
What is its most important limitation?Key limitation: 2D flow model is not for patients under 18, 4D flow, extreme congenital distortion or low-SNR data; clinician review/editing is required.
Clinical takeaway. Clinical role: Cardiac MRI ventricular function and 2D phase-contrast flow quantification
Evidence takeaway. Evidence from the reviewed source record: FDA flow-model validation used 167 cases from 61 subjects. The packet contains multiple Dice contexts, so no single Dice result is presented.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Cardiac MRI ventricular function and 2D phase-contrast flow quantification
LV/RV volumes, ejection fraction, mass and indexed measurements; aortic/pulmonary vessel masks and forward/backward/net flow, regurgitant fraction, maximum velocity and pressure gradient.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
FDA flow-model validation used 167 cases from 61 subjects. The packet contains multiple Dice contexts, so no single Dice result is presented.
FDA source
Exact FDA submission
Checked 2026-09-05
Exact FDA flow-model validation is stated without pooling it with the separate ACR regulatory summary or promoting a single Dice result.
Segmentation agreement does not establish diagnostic sensitivity.
Reported specificity
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-05
No diagnostic specificity established.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
AI4CMR v2.0 ACR regulatory performance study summary
DesignStandalone performance summary
PopulationAdult
Scopeexact submission
Tested version2
Samplen=296
Sites1
IndependenceIndependence not established
K252084
Preserved baseline ACR study. Exact FDA flow validation is described separately and should not be assumed the same cohort.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
Not established in reviewed sources
Reviewed sources checked
Exact FDA submission
Checked 2026-09-04
No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.
Pricing & contractsPublic price, contract terms, and reimbursement
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: DICOM 1.5T or 3T cardiac MR cine and two-dimensional phase-contrast flow acquisitions
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Unresolved route: Not established for the exact route.
Scope: Exact FDA submission. Cloud plug-in architecture does not establish data region, retention or local implementation configuration.
Confirm processing location, queue ownership, exclusions and exact AI build.
Field checked 2026-09-05 ·
Returned objects
Source context, not route validation: LV/RV volumes, ejection fraction, mass and indexed measurements; aortic/pulmonary vessel masks and forward/backward/net flow, regurgitant fraction, maximum velocity and pressure gradient.
Scope: Exact FDA submission.
Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.
Unresolved route: LV/RV volumes, ejection fraction, mass and indexed measurements; aortic/pulmonary vessel masks and forward/backward/net flow, regurgitant fraction, maximum velocity and pressure gradient.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
AI4CMR's security & compliance page states that AI4CMR operates cloud sites in multiple global regions so that data remains within the appropriate jurisdiction in compliance with GDPR and local data-protection regulations, and maintains cloud-based disaster recovery systems to preserve availability and data integrity.
Product family
Checked 2026-10-27
Vendor statement, not an attestation. The page names the AI4CMR product without distinguishing v1.0 (K220624) from v2.0 (K252084); exact-release scope is not established. The page's listed QMS/regulatory standards (ISO 13485, ISO 14971, IEC 62304, MDR, 21 CFR 820) are not treated as security evidence; no certificate or report was read.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-06Last searched
21Fields reviewed
10Source classes checked
0Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads
Stored PubMed and clinical-trial arrays are empty and were screened. The current discovery snapshot contains 0 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, acr ai central product, fda decision summary, vendor product page, literature index, trial registry, recall database, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission
Bounded web search on 2026-10-26 (query: "Ai4medimaging reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. No result was a vendor or payer page naming this product with coding or payment; any results were general billing guidance. This records what was found, not that none exists.
Deployment: Not verified - checked 2026-09-05 - Exact FDA submission
Cloud plug-in architecture does not establish data region, retention or local implementation configuration.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Installation timeline: Not yet reviewed
Training: Not verified - checked 2026-09-05 - Exact FDA submission
CMR reader training and flow-editing requirements require vendor confirmation.
Monitoring: Not verified - checked 2026-09-05 - Exact FDA submission
Version-update validation and flow-edit monitoring require confirmation.
Authorized purpose: Myomics assists qualified medical professionals with viewing, post-processing and qualitative/quantitative evaluation of 3T cardiovascular MR images in DICOM format, including heart and adjacent-vessel measurements; semi-automated machine-learning workflows are intended for adults and contribute to comprehensive diagnostic decision-making.
Sonic DL is deep-learning MRI reconstruction for highly undersampled or accelerated cardiac acquisitions on compatible GE 1.5T and 3.0T MRI systems for pediatric and adult patients.
Accessory acquisition, reconstruction, and display of cardiovascular MR images on compatible 1.5T and 3T whole-body MRI systems for trained-physician interpretation.
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.